Thyrocare Technologies Limited (THYROCARE) fair value: what the stock is really worth
As of Nov 16, 2026: fair value (intrinsic value) of Thyrocare Technologies Limited stock ₹378, price ₹510, that is 25.9% below the price, quality 73 out of 100. Rating: overvalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Thyrocare Technologies Limited
THYROCARE · NSEExpensive (fair value 26% below the price), but solid company and rising price: meets 2 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 15, 2026.
How to read this chart
60‑month range ₹127.82 – ₹987,151 · fair‑value band ₹234.38 – ₹502.04 · the ₹509.65 price screens above the ₹377.52 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 15, 2026.
Every Wednesday you see whether Thyrocare Technologies is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates through three segments: Diagnostic Testing Services, Imaging Services, and Others.
Show moreShow less
The Diagnostic Testing Services segment engages in the selling of consumables used for collection, and promotion of pathology. The Imaging Services segment sells radio-pharmaceutical and consumables for reporting.
The Others segment engages in the sale of testing equipment and consumables; and glucometer and glucostrips under the brand name sugarscan. The company offers diagnostic and pathological services. The company was founded in 1996 and is based in Navi Mumbai, India.
Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited.
Stock analysis
Thyrocare Technologies Limited (THYROCARE) currently trades at ₹509.65, while our model-based Fair Value estimate is ₹377.52, 26% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of ₹227.79 per share, and 0 of the 26 models we run sit above the ₹509.65 price.
Bear case: the Economic Profit group reads lowest at ₹81.89, and 26 of the 26 models stay below the price. Data coverage for this calculation is high.
Scenario range: ₹234.38 (bear) to ₹502.04 (bull), the price of ₹509.65 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 73/100 (solid quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Thyrocare Technologies Limited reported revenue of ₹8.3B in FY2026 versus ₹5.9B in FY2022, a compound +8.9%/yr. Reported net income was ₹1.6B in FY2026, compounding −1.9%/yr from FY2022.
Key figures
Market cap ₹81.1B (≈ $861M) Small · P/E ratio 56.8 · P/S ratio 9.26 · EPS (TTM) ₹8.97 · Dividend yield 1.8% · Net margin 20.1% · Return on equity 28.8% · Return on assets (EBIT) 21.8% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 88 out of 100 (medium confidence).
What moves the price
The share trades about 22% below its 52-week high and 47% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −10% fair-value upside, at −26%, THYROCARE screens richer than that median.
Fair Value models
All 26 models by family
The fair value above starts from this blend and is adjusted for dilution from new shares.
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Growth Forecast
Compare Thyrocare Technologies Limited with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Diagnostics & Research · 150 stocks
Valuation Multiplesvs Diagnostics & Research median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- PEG ratio by industry
- Revenue growth by industry
- Stock screener with 62 metrics
- Undervalued stocks: Indian Stocks
- Valuation of the India market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Diagnostics & Research stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| WuXi AppTec Co 603259 | ¥144.41 | ¥164.66 | +14% | vs THYROCARE |
| IQVIA Holdings IQV | $265.12 | $291.63 | +10% | vs THYROCARE |
| Illumina, Inc ILMN | $207.01 | $227.71 | +10% | vs THYROCARE |
| Thermo Fisher Scientific Inc TMO | $700.22 | $686.04 | −2% | vs THYROCARE |
| Danaher Corporation DHR | $233.02 | $209.18 | −10% | vs THYROCARE |
| IDEXX Laboratories, Inc IDXX | $704.23 | $496.48 | −30% | vs THYROCARE |
| Lonza Group LONN | CHF 670.20 | CHF 259.80 | −61% | vs THYROCARE |
| Mettler-Toledo International Inc MTD | $1,739 | $655.06 | −62% | vs THYROCARE |
| Agilent Technologies, Inc A | $173.96 | $64.53 | −63% | vs THYROCARE |
| Waters Corporation WAT | $460.25 | $91.26 | −80% | vs THYROCARE |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Thyrocare Technologies Limited (THYROCARE) overvalued or undervalued?
What is the fair value of THYROCARE?
What is the quality score of THYROCARE?
What is the price target for Thyrocare Technologies Limited (THYROCARE)?
What is the Thyrocare Technologies Limited stock forecast for 2026?
What is the revenue of Thyrocare Technologies Limited (THYROCARE)?
Does Thyrocare Technologies Limited pay a dividend?
How much is the dividend of Thyrocare Technologies Limited (THYROCARE)?
What growth is priced into Thyrocare Technologies Limited (THYROCARE)?
What discount rate (WACC) does the fair value of THYROCARE use?
What is a reverse DCF?
How much growth has Thyrocare Technologies Limited (THYROCARE) delivered so far?
How fast is the sector of Thyrocare Technologies Limited (THYROCARE) growing?
What is the free cash flow yield of Thyrocare Technologies Limited (THYROCARE)?
What is the intrinsic value of Thyrocare Technologies Limited (THYROCARE)?
Is Thyrocare Technologies Limited stock overvalued or undervalued in 2026?
Is fair value the same as the market price of THYROCARE?
How much is Thyrocare Technologies Limited worth?
What do the bullish and bearish scenarios say about THYROCARE?
What is the P/E ratio of THYROCARE?
How solid is the balance sheet of Thyrocare Technologies Limited (THYROCARE)?
How far is THYROCARE from its 52-week high?
Which stocks are comparable to Thyrocare Technologies Limited?
Is Thyrocare Technologies Limited stock attractive at the current price?
How is the fair value of THYROCARE calculated?
Is it still worth investing in stocks now?
What is the share price of Thyrocare Technologies Limited (THYROCARE)?
What should I pay attention to with Thyrocare Technologies Limited right now?
Where does the earnings growth of Thyrocare Technologies Limited (THYROCARE) come from?
Key figures of Thyrocare Technologies Limited
How large is the market capitalisation of Thyrocare Technologies Limited (THYROCARE)?
What is the P/S ratio of Thyrocare Technologies Limited (THYROCARE)?
What are the earnings per share of Thyrocare Technologies Limited (THYROCARE)?
What is the dividend yield of Thyrocare Technologies Limited (THYROCARE)?
What is the net margin of Thyrocare Technologies Limited (THYROCARE)?
What is the return on equity of Thyrocare Technologies Limited (THYROCARE)?
What is the EBIT return on assets of Thyrocare Technologies Limited (THYROCARE)?
What is the operating margin of Thyrocare Technologies Limited (THYROCARE)?
How fast is revenue growing at Thyrocare Technologies Limited (THYROCARE)?
How fast are earnings growing at Thyrocare Technologies Limited (THYROCARE)?
How much net cash does Thyrocare Technologies Limited (THYROCARE) hold?
Watch Thyrocare Technologies Limited in the live analysis
One click puts Thyrocare Technologies Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.